SCHEMBL15469074

SCHEMBL15469074

CCOC(=O)Cn1c(C(C)C)cccc1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
KDM4E B2RXH2 3/20 0.49
TSHR P16473 3/20 0.47
MAPT P10636 2/20 0.47
HTT P42858 2/20 0.47
HSD17B10 Q99714 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
RAB9A P51151 1/20 0.46
ALOX15 P16050 1/20 0.45
GAA P10253 1/20 0.45
GSK3A P49840 1/20 0.44
GSK3B P49841 1/20 0.44
PIN1 Q13526 1/20 0.43
PIN4 Q9Y237 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2827984 0.81 ALDH1A1 (0.59) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL22114573 0.79 ALDH1A1 (0.56) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL20149586 0.76 ALDH1A1 (0.37) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL1988320 0.73 ALDH1A1 (0.66) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL20037150 0.73 ALDH1A1 (0.57) ALDH1A1MEN1KMT2ATDP1KDM4E
SCHEMBL17772670 0.70 ALDH1A1 (0.56) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL21840743 0.70 ALDH1A1 (0.53) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL11277508 0.70 KDM4E (0.58) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL23923170 0.70 KDM4E (0.47) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL6309300 0.69 ALDH1A1 (0.56) ALDH1A1MEN1KMT2ATDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9085561-B2 Cyclic urea- or lactam-substituted quinoxaline-type piperidines as ORL-1 modulators PURDUE PHARMA L.P. (US) 2015-07-21 US disclosed
US-20140045830-A1 CYCLIC UREA- OR LACTAM-SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF SHIONOGI & CO., LTD. (JP) 2014-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140045830-A1 CYCLIC UREA- OR LACTAM-SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF QPCT, UBXN1, NQO2 ALDH1A1 1232/4885MEN1 2991/4885KMT2A 2129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.